Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Joining forces to drive biomedical translation.

Shi TZ, Liang H, Liang X, Zhan Q, Dai K, Alving BM, Liu D, Dai J, Shekhar A, Fu X.

Sci Transl Med. 2015 Feb 18;7(275):275ed1. doi: 10.1126/scitranslmed.aaa2363. No abstract available.

PMID:
25695997
2.

Response to: "Rescuing the NIH before it is too late".

Alexander DF, Alving BM, Battey JF, Berg JM, Collins FS, Fauci AS, Gallin JI, Grady PA, Hodes RJ, Hrynkow SH, Insel TR, Jones JF, Katz SI, Landis SC, Li TK, Lindberg DA, Nabel EG, Niederhuber JE, Pettigrew RI, Rodgers GP, Ruffin J, Scarpa A, Schwartz DA, Sieving PA, Straus SE, Tabak LA, Volkow ND.

J Clin Invest. 2006 Jun;116(6):1462-3.

3.

Executive summary of the Strategic Plan for National Institutes of Health Obesity Research.

Spiegel AM, Alving BM.

Am J Clin Nutr. 2005 Jul;82(1 Suppl):211S-214S. doi: 10.1093/ajcn/82.1.221S.

PMID:
16002822
4.

Consultations on patients with venous or arterial diseases.

Alving BM, Francis CW, Hiatt WR, Jackson MR.

Hematology Am Soc Hematol Educ Program. 2003:540-58. Review.

PMID:
14633798
5.

Platelet substitutes: the reality and the potential.

Alving BM.

Vox Sang. 2002 Aug;83 Suppl 1:287-8. Review. No abstract available.

PMID:
12617154
6.

How I treat heparin-induced thrombocytopenia and thrombosis.

Alving BM.

Blood. 2003 Jan 1;101(1):31-7. Epub 2002 Aug 15. Review. No abstract available.

7.

Update in hematology.

Catlett JP, Alving BM.

Ann Intern Med. 2002 Jan 15;136(2):136-43. Review. No abstract available.

PMID:
11790066
8.

Diagnosis and management of patients with the antiphospholipid syndrome.

Alving BM.

J Thromb Thrombolysis. 2001 Sep;12(1):89-93. Review.

PMID:
11711694
9.

Update in hematology.

Schechter GP, Dave HP, Alving BM.

Ann Intern Med. 2001 Jan 2;134(1):38-46. Review. No abstract available.

PMID:
11187419
10.

Parvovirus B19: implications for transfusion medicine. Summary of a workshop.

Brown KE, Young NS, Alving BM, Barbosa LH.

Transfusion. 2001 Jan;41(1):130-5.

PMID:
11161258
11.

Fibrin sealant in preclinical and clinical studies.

Jackson MR, Alving BM.

Curr Opin Hematol. 1999 Nov;6(6):415-9. Review.

PMID:
10546796
12.

Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial.

Jackson MR, Gillespie DL, Longenecker EG, Goff JM, Fiala LA, O'Donnell SD, Gomperts ED, Navalta LA, Hestlow T, Alving BM.

J Vasc Surg. 1999 Sep;30(3):461-6.

PMID:
10477639
13.

Near-site monitoring of the antiplatelet drug abciximab using the Hemodyne analyzer and modified thrombelastograph.

Greilich PE, Alving BM, Longnecker D, Carr ME Jr, Whitten CW, Chang AS, Reid TJ.

J Cardiothorac Vasc Anesth. 1999 Feb;13(1):58-64.

PMID:
10069286
14.

Physiologic responses of cross-linked hemoglobin in endotoxin-treated rats.

Goff JM, Jackson MR, Taher M, Cutting MA, Alving BM, Krishnamurti C.

Artif Cells Blood Substit Immobil Biotechnol. 1999 Jan;27(1):11-21.

PMID:
10063435
15.

A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets.

Reid TJ, Snider R, Hartman K, Greilich PE, Carr ME, Alving BM.

Vox Sang. 1998;75(4):270-7.

PMID:
9873262
16.

Hemostatic efficacy of a fibrin sealant dressing in an animal model of kidney injury.

Jackson MR, Taher MM, Burge JR, Krishnamurti C, Reid TJ, Alving BM.

J Trauma. 1998 Oct;45(4):662-5.

PMID:
9783601
17.

The incidence of heparin-induced antibodies in patients undergoing vascular surgery: a prospective study.

Jackson MR, Gillespie DL, Chang AS, Longenecker EG, Peat RA, Alving BM.

J Vasc Surg. 1998 Sep;28(3):439-44; discussion 445.

18.

Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.

Jackson MR, Danby CA, Alving BM.

Ann Thorac Surg. 1997 Dec;64(6):1815-7. Review.

PMID:
9436582
19.

Cardiovascular toxicity of human cross-linked hemoglobin in a rabbit endotoxemia model.

Krishnamurti C, Carter AJ, Maglasang P, Hess JR, Cutting MA, Alving BM.

Crit Care Med. 1997 Nov;25(11):1874-80.

PMID:
9366773
20.

Frozen platelets and platelet substitutes in transfusion medicine.

Alving BM, Reid TJ, Fratantoni JC, Finlayson JS.

Transfusion. 1997 Aug;37(8):866-76. No abstract available.

PMID:
9280335
21.

Hemostatic efficacy of a fibrin sealant-based topical agent in a femoral artery injury model: a randomized, blinded, placebo-controlled study.

Jackson MR, Friedman SA, Carter AJ, Bayer V, Burge JR, MacPhee MJ, Drohan WN, Alving BM.

J Vasc Surg. 1997 Aug;26(2):274-80.

22.

Diagnosis of heparin-induced thrombocytopenia in the vascular surgery patient.

Jackson MR, Krishnamurti C, Aylesworth CA, Alving BM.

Surgery. 1997 Apr;121(4):419-24.

PMID:
9122872
23.

Recognition and management of heparin-induced thrombocytopenia (HIT) and thrombosis.

Alving BM, Krishnamurti C.

Semin Thromb Hemost. 1997;23(6):569-74. Review.

PMID:
9469632
24.

A modified thromboelastographic method for monitoring c7E3 Fab in heparinized patients.

Greilich PE, Alving BM, O'Neill KL, Chang AS, Reid TJ.

Anesth Analg. 1997 Jan;84(1):31-8.

PMID:
8988995
25.

Fibrin sealant: current and potential clinical applications.

Jackson MR, MacPhee MJ, Drohan WN, Alving BM.

Blood Coagul Fibrinolysis. 1996 Nov;7(8):737-46. Review.

PMID:
9034553
26.

Severe vitamin K deficiency induced by occult celiac disease BR96-026.

Avery RA, Duncan WE, Alving BM.

Am J Hematol. 1996 Sep;53(1):55. No abstract available.

27.

Resistance to activated protein C: a common inherited cause of venous thrombosis.

Gillespie DL, Carrington LR, Griffin JH, Alving BM.

Ann Vasc Surg. 1996 Mar;10(2):174-7.

PMID:
8733870
28.

Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model.

Olsen SB, Tang DB, Jackson MR, Gomez ER, Ayala B, Alving BM.

Circulation. 1996 Jan 15;93(2):327-32.

PMID:
8548906
29.

Antithrombotic effects of hirulog in a rat carotid endarterectomy model.

Jackson MR, Reid TJ, Tang DB, O'Donnell SD, Gomez ER, Alving BM.

J Surg Res. 1996 Jan;60(1):15-22.

PMID:
8592407
30.

PAI-1-resistant t-PA: low doses prevent fibrin deposition in rabbits with increased PAI-1 activity.

Krishnamurti C, Keyt B, Maglasang P, Alving BM.

Blood. 1996 Jan 1;87(1):14-9.

31.

Use of antithrombin III concentrates to correct antithrombin III deficiency during vascular surgery.

Jackson MR, Olsen SB, Gomez ER, Alving BM.

J Vasc Surg. 1995 Dec;22(6):804-7.

32.

Acquired von Willebrand's disease: a rare manifestation of postpartum thyroiditis.

Aylesworth CA, Smallridge RC, Rick ME, Alving BM.

Am J Hematol. 1995 Nov;50(3):217-9. Review.

PMID:
7485084
33.

Effect of fibrin structure on plasmin-mediated dissolution of plasma clots.

Carr ME Jr, Alving BM.

Blood Coagul Fibrinolysis. 1995 Sep;6(6):567-73.

PMID:
7578900
34.

Fibrin sealant: summary of a conference on characteristics and clinical uses.

Alving BM, Weinstein MJ, Finlayson JS, Menitove JE, Fratantoni JC.

Transfusion. 1995 Sep;35(9):783-90.

PMID:
7570942
35.

Increased anticardiolipin antibodies associated with the development of anetoderma in HIV-1 disease. Military Medical Consortium for the Advancement of Retroviral research (MMCARR).

Lindstrom J, Smith KJ, Skelton HG, Redfield R, Alving BM, Wagner KF, Lupton GP.

Int J Dermatol. 1995 Jun;34(6):408-15.

PMID:
7657440
36.

Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model.

Hamelink JK, Tang DB, Barr CF, Jackson MR, Reid TJ, Gomez ER, Alving BM.

J Vasc Surg. 1995 Mar;21(3):492-8.

37.

Hemostatic assessment of patients before tonsillectomy: a prospective study.

Close HL, Kryzer TC, Nowlin JH, Alving BM.

Otolaryngol Head Neck Surg. 1994 Dec;111(6):733-8.

PMID:
7991252
38.

Hirulog therapy for heparin-associated thrombocytopenia and deep venous thrombosis.

Reid T 3rd, Alving BM.

Am J Hematol. 1994 Apr;45(4):352-3. No abstract available.

PMID:
8192819
39.

Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis.

Krishnamurti C, Vukelja SJ, Alving BM.

Thromb Res. 1994 Mar 15;73(6):419-30.

PMID:
8073394
40.

Role of plasminogen activator inhibitor-1 in promoting fibrin deposition in rabbits infused with ancrod or thrombin.

Krishnamurti C, Bolan C, Colleton CA, Reilly TM, Alving BM.

Blood. 1993 Dec 15;82(12):3631-6.

41.

A quantitative thrombin time for determining levels of hirudin and Hirulog.

Reid TJ 3rd, Alving BM.

Thromb Haemost. 1993 Oct 18;70(4):608-16.

PMID:
8115987
42.

Association of protein S deficiency with thrombosis in a kindred with increased levels of plasminogen activator inhibitor-1.

Bolan CD, Krishnamurti C, Tang DB, Carrington LR, Alving BM.

Ann Intern Med. 1993 Oct 15;119(8):779-85.

PMID:
8379599
43.

The hypercoagulable states.

Alving BM.

Hosp Pract (Off Ed). 1993 Feb 15;28(2):109-14, 119-21. Review.

PMID:
8432749
44.

ATP specifically bound as a hapten to a monoclonal anti-phospholipid antibody retains phosphate donor activity.

Wassef NM, Swartz GM, Alving BM, Alving CR.

Biochem Biophys Res Commun. 1993 Jan 29;190(2):582-8.

PMID:
8381281
45.

Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.

Alving BM, Comp PC.

Am J Obstet Gynecol. 1992 Oct;167(4 Pt 2):1184-91. Review.

PMID:
1415444
46.

Effect of ultrasound on tissue-type plasminogen activator-induced thrombolysis.

Lauer CG, Burge R, Tang DB, Bass BG, Gomez ER, Alving BM.

Circulation. 1992 Oct;86(4):1257-64.

PMID:
1394932
47.
48.

Pharmacology and mechanism of action of ancrod: potential for inducing thrombosis.

Krishnamurti C, Bolan CD, Reid TJ 3rd, Alving BM.

Blood. 1992 May 1;79(9):2492. No abstract available.

PMID:
1571563
49.

Effect of plasminogen activator inhibitor-1 on tissue-type plasminogen activator-induced fibrinolysis.

Carr ME Jr, Krishnamurti C, Alving BM.

Thromb Haemost. 1992 Jan 23;67(1):106-10.

PMID:
1615464
50.

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.

Krishnamurti C, Alving BM.

Semin Thromb Hemost. 1992 Jan;18(1):67-80. Review. No abstract available.

PMID:
1374195

Supplemental Content

Loading ...
Support Center